CONCERNS ABOUT THE GENETICS OF PREECLAMPSIA - REPLY

被引：0
|
作者：
HAYWARD, C
BROCK, DJH
机构：
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1993年 / 52卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：1013 / 1014
页数：2
相关论文
共 50 条
  • [31] GENETICS OF PREECLAMPSIA
    COOPER, DW
    BRENNECKE, SP
    WILTON, AN
    [J]. HYPERTENSION IN PREGNANCY, 1993, 12 (01) : 1 - 23
  • [32] THE GENETICS OF PREECLAMPSIA
    CHESLEY, LC
    [J]. HYPERTENSION IN PREGNANCY, 1993, 12 (01) : R7 - R10
  • [33] Reply to Sumiyoshi, "Concerns about the interpretation of treatment effects"
    Gu, Xin
    Zhou, Pingyu
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (08)
  • [34] Reply to: "Concerns about cognitive performance at chance level"
    Toth, Adam J.
    Campbell, Mark J.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [35] Concerns about risks of irradiation during pregnancy -: Reply
    Berg, GEB
    Nyström, EH
    Jacobsson, L
    Lindberg, S
    Lindstedt, RG
    Niklasson, CA
    Norén, AH
    Westphal, OGA
    Mattsson, S
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (12) : 2195 - 2195
  • [36] Concerns about laser pointers and macular damage - In reply
    Robertson, DM
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (11) : 1731 - 1732
  • [37] Reply to: "Concerns about cognitive performance at chance level"
    Adam J. Toth
    Mark J. Campbell
    [J]. Scientific Reports, 11
  • [38] Concerns about new proposals for haemochromatosis screening Reply
    Adams, Paul C.
    Jeffrey, Gary P.
    Ryan, John
    [J]. LANCET, 2023, 401 (10403): : 692 - 692
  • [39] The HELOISE Study: Concerns About Trial Design Reply
    Shah, Manish A.
    Herraez-Baranda, Luis A.
    Garg, Amit
    Tabernero, Josep
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (03) : 303 - +
  • [40] Reply to the concerns raised by McKenna and Heaney about COSMIN
    Mokkink, Lidwine B.
    Terwee, Caroline B.
    de Vet, Henrica C. W.
    Bouter, Lex M.
    Alonso, Jordi A.
    Patrick, D.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 857 - 859
12345